RecruitingNCT01885767
Neurofibromatosis (NF) Registry Portal
Neurofibromatosis (NF) Registry Portal Funded by Children's Tumor Foundation
Sponsor
The Children's Tumor Foundation
Enrollment
20,000 participants
Start Date
Jun 1, 2012
Study Type
OBSERVATIONAL
Conditions
Summary
The NF Registry is a database of patient-reported symptoms, treatments, and experiences with their neurofibromatosis disease. It is a contact registry to relay clinical trial opportunities to targeted patient subgroups, and to supply de-identified disease data to researchers. It has the potential to become a natural history resource.
Eligibility
Inclusion Criteria3
- Diagnosed with NF1
- Diagnosed with NF2
- Diagnosed with Schwannomatosis
Exclusion Criteria1
- Failure to complete account registration
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01885767
Related Trials
Real-World Treatment Study of Koselugo (Selumetinib)
NCT0636040612 locations
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
NCT047509281 location
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
NCT025440226 locations
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
NCT056846921 location
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
NCT0584966219 locations